Key result
Glucosyl hesperidin reduces systolic blood pressure in hypertensive rats via nitric oxide-mediated vasodilation.
Answers are grounded in this paper and cite their sources.
Glucosyl hesperidin (G-hesperidin) is a water-soluble derivative of hesperidin. In the present study, the short-term effects of G-hesperidin and hesperetin, a putative metabolite of G-hesperidin, in spontaneously hypertensive rats (SHR) and in normotensive Wistar-Kyoto rats (WKY) were investigated. Single oral administration of G-hesperidin (10 to 50 mg/kg) induced a dose-dependent reduction in systolic blood pressure (SBP) in SHR, but had no effects in WKY. Intraperitoneal injection of hesperetin (50 mg/kg) into SHR also caused a significant reduction in SBP. The depressor effect was significantly inhibited by a nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester. Moreover, hesperetin (10(-5) M) enhanced endothelium-dependent relaxation induced by acetylcholine, but had no effect on endothelium-independent relaxation induced by sodium nitroprusside in isolated aortas from SHR. These data suggest that the hypotensive effect of hesperetin in SHR is associated with nitric oxide-mediated vasodilation. Therefore, this effect may be involved in the mechanisms by which G-hesperidin lowers blood pressure in hypertension.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2008) studied Hypertension (spontaneously hypertensive rats). Glucosyl hesperidin and hesperetin vs. Normotensive Wistar-Kyoto rats (WKY) and N(G)-nitro-L-arginine methyl ester inhibition was evaluated on Systolic blood pressure (SBP) and endothelium-dependent relaxation. Glucosyl hesperidin and hesperetin reduced systolic blood pressure in spontaneously hypertensive rats via nitric oxide-mediated vasodilation.
Synapse has enriched 10 related papers. Consider them for comparative context: